Home Who we are Leadership

Leadership

Being a family-owned company enables us to take a long-term view. Our leaders value long-lasting solutions rather than short-term gains.

Executive Management

Tobias S. Christensen

President & CEOM.Sc. Chem. Eng.

Henrik Parker

Executive Vice President, CFOMSc in Business Economics and Auditing

Claes C. Strøm

Executive Vice President, CCOMD, PhD, BBA

Lars L. Thomsen

Executive Vice President, CMOMD, PhD, DMSc

Milena Jordanova Olsen

Executive Vice President, General CounselAttorney at Law

Ingeborg Lohmann Laursen

Executive Vice President, Quality & Regulatory AffairsCand. Pharm.

Ditte Lindboe

Executive Vice President, HRCand. Merc. HRM

Thomas B. Riisager

Executive Vice President, Business Development & Strategy

Steen Søgaard

Executive Vice President, Product Supply & DevelopmentM.Sc. Chemical Engineering , Diploma in Managing Medical Product Innovation

Affiliate Management

Terry Robertson

Vice President, Northern Europe & Managing Director, Pharmacosmos UK/IE

Josh Franklin

President, Pharmacosmos Therapeutics Inc., US

Kathy Liu

Managing Director, Pharmacosmos China

Lars Toustrup-Andersen

Managing Director, Germany

Malin Winterleijon

Managing Director, Nordics

Board of Directors

Jacob Tolstrup

Chairman of the Board of Directors

Lars Christensen

Deputy Chairman of the BoardMD

Dr. Martin Holst Lange

Member of the Board

Milena Jordanova Olsen

Member of the BoardAttorney at Law

Lars Green

Member of the Board
Pharmacosmos is …

A global pioneer in carbohydrate chemistry and a leader in the development of innovative treatments for patients suffering from iron deficiency and iron deficiency anaemia.

Who we are

As a family-held company, we are cognisant of how work shapes who we are and who we aspire to become.

Aspiration & Values

We want to change the way iron deficiency is prevented and treated.

Our defining moments

The entrepreneurship journey has taken us from a small dairy nestled in a tiny village to a state-of-the-art production facility with the capacity to meet the entire world’s demand for intravenous iron.

Global presence

Our global presence is strong, thanks to our skilled colleagues and partners in all the major pharmaceutical markets. Today, we are represented in more than 40 countries. This is the key to our accelerated growth and will lay the foundation for future regional and global innovation.

Sustainability

We see ourselves as a business based on trust and characterised by a strong sense of responsibility.

Code of conduct

We do not compromise on quality or business ethics, and we take action. Even when confronted with difficult situations, we make decisions that are ethically driven.